Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Contract Research & Services
Contract Services
Return to: PBR Home | Contract Research & Services | Contract Services

Contract Services

Arena subsidiary inks marketing, supply deal with Abic for BELVIQ in Israel By PBR Staff Writer
Arena Pharmaceuticals' subsidiary has entered into an exclusive marketing and supply agreement for BELVIQ (lorcaserin HCl) with Teva Pharmaceutical Industries' Israeli subsidiary, Abic Marketing Limited.
Contract Research & Services > Contract Services > News
Anacor Pharmaceuticals, Sandoz ink deal to commercialize KERYDIN in US Anacor Pharmaceuticals has entered into an exclusive agreement with Sandoz, a Novartis company, pursuant to which Sandoz will distribute and commercialize Anacor’s drug KERYDIN (tavaborole) topical solution, 5% in the United States.
Contract Research & Services > Contract Services > News Celladon announces In-license of stem cell factor development program Celladon, a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium dysregulation has announced an exclusive, global license from Enterprise Partners Venture Capital for gene therapy applications of the membrane-bound form of the Stem Cell Factor gene (mSCF) for treatment of cardiac ischemia.
Contract Research & Services > Contract Services > News
See more Contract Services news

Latest Contract Services News and Insight

View all Contract Services news or find news targeted to your interests
Lannett inks deal with Symplmed for US distribution of authorized generic of ACEON
By PBR Staff Writer
US-based Lannett has signed an agreement with Symplmed Pharmaceuticals to be the exclusive distributor in the US of an authorized generic version of ACEON (perindopril erbumine tablets) in 2mg, 4mg and 8mg dosage strengths.
Contract Research & Services > Contract Services > News
Mymetics to manufacture Imugene's Virosome based HER-Vaxx cancer immunotherapy
By PBR Staff Writer
Swiss biotechnology firm Mymetics has signed an exclusive agreement with Imugene, an Australian biopharmaceutical company, to manufacture and develop its cancer immunotherapy HER-Vaxx.
Contract Research & Services > Contract Services > News
MediWound announces NexoBrid marketing approval from Israeli Ministry of Health
MediWound has received authorization from the Israeli Ministry of Health to market and distribute NexoBrid for the removal of dead or damaged tissue, known as eschar, in adults with deep partial- and full-thickness thermal burns. MediWound intends to launch NexoBrid in Israel this quarter.
Contract Research & Services > Contract Services > News
Isis Pharmaceuticals earns $1 million from GSK for advancing ISIS-TTR Rx
Isis Pharmaceuticals has announced that it has earned a $1 million milestone payment from GlaxoSmithKline (GSK) related to the advancement of the Phase 2/3 study of ISIS-TTRRx in patients with familial amyloid polyneuropathy (FAP).
Contract Research & Services > Contract Services > News
Iroko Pharmaceuticals, EMS collaborate to commercialize Zorvolex in Brazil
By PBR Staff Writer
An affiliate of Iroko Pharmaceuticals has signed a licensing agreement with EMS for the exclusive rights to market and sell Zorvolex (diclofenac) capsules in Brazil.
Contract Research & Services > Contract Services > News
BIAL, moksha8 partner to commercialize Eslicarbazepine Acetate in Brazil and Mexico
BIAL, a research based international pharmaceutical company, and moksha8, a leading specialty pharmaceutical company in Latin America, have announced an exclusive license for the commercialization of eslicarbazepine acetate (Zebinix/ (Exalief) in Brazil and Mexico for the treatment of epilepsy.
Contract Research & Services > Contract Services > News
Galderma finalizes major expansion in aesthetic and corrective dermatology in US, Canada
Galderma announced that it has gained full rights to distribute Restylane, Perlane, Emervel, Sculptra and Dysport from Valeant Pharmaceuticals International.
Contract Research & Services > Contract Services > News
Lightlake inks deal with contract manufacturer for naloxone to treat opioid overdose
By PBR Staff Writer
UK-based biopharmaceutical firm Lightlake Therapeutics has signed an agreement with a commercial contract manufacturer to start production of its opioid overdose reversal treatment, naloxone, an injectable medicine that can reverse the overdose of prescription and illicit opioids.
Contract Research & Services > Contract Services > News
Par Pharmaceutical begins shipment of Fluphenazine Decanoate injection, USP
Par Pharmaceutical Companies has received final approval from the US Food and Drug Administration for its Abbreviated New Drug Application for fluphenazine decanoate injection, USP 25 mg/mL.
Contract Research & Services > Contract Services > News
ISCO inks deal including certain terms for definitive license agreement with Rohto
By PBR Staff Writer
US-based biotechnology firm International Stem Cell (ISCO) has entered into a research agreement with Rohto Pharmaceutical (Rohto), a Japanese pharmaceutical firm, which develops new technology for the medical and cosmetics markets.
Contract Research & Services > Contract Services > News
View all Contract Services news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250